METLIFE INC

MetLife’s Q1 earnings look up, but a deep dive reveals modest gains, inflated loss reserves, high‑risk bond exposure, and governance concerns that could erode its true profitability.

MetLife’s latest shareholder meeting signals a strategic pivot to digital, ESG leadership and flexible capital, boosting long‑term value for institutional investors.

MetLife insider buying: new Form 4 filings reveal directors buying stock below market price, using deferred compensation and GRATs—raises transparency and governance concerns.

MetLife’s 2026 Q4 and annual results reveal modest gains in operating income, a low debt‑equity ratio, and positive free cash flow, while highlighting gaps in digital manufacturing, sustainability, and expansion strategies for long‑term competitiven…

MetLife’s “Footwork for Futures” soccer‑based CSR campaign boosts brand equity, employee engagement, and micro‑influencer reach while driving global education and sports impact.

MetLife’s early‑May Rule 144 filings show routine equity rebalancing and executive share gains, underscoring stable ownership and compliance without market impact.

MetLife’s disciplined capital strategy, strong Tier 1 ratio and AI‑driven digital push position it to weather market volatility while boosting shareholder value.

MetLife’s Q1 earnings reveal a push for climate‑tech, scrutiny of an unsolicited tender, and private‑credit insights—examining transparency, ESG impact, and investor protection.

MetLife’s vague pre‑tax variable income estimate sparks investor scrutiny, highlighting gaps in disclosure and potential Cadence Bank influence.

MetLife strengthens investment strategy by appointing Andrea Drasites to lead real‑estate and agriculture finance, while its Rule 144 share sale shows routine portfolio management.